echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Ann Rheum Dis: Using methotrexate to treat rheumatoid arthritis can reduce the risk of cardiovascular disease

    Ann Rheum Dis: Using methotrexate to treat rheumatoid arthritis can reduce the risk of cardiovascular disease

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Rheumatoid arthritis (RA) is a common type of autoimmune disease.


    The study used a multicenter, prospective cohort of RA veterans to identify incidental CVD events (coronary artery disease (CAD), stroke, heart failure (HF) hospitalization, CVD death) in the cohort


    Among 2044 RA patients (90% male, average age 63.


    The use of MTX was associated with a 24% reduction in the risk of compound CVD events (HR 0.



    Figure Forest diagram of the impact of methotrexate on CVD events

    It can be seen that the use of MTX therapy in RA patients is associated with a reduction in the risk of CVD events, especially the hospitalization rate for heart failure


    The use of MTX therapy in RA patients is associated with a reduced risk of CVD events, especially heart failure hospitalization rates


    Original source:

    Original source:

    Tate M Johnson.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.